Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study
2022 · HPB · 29 citations
https://doi.org/10.1016/j.hpb.2022.01.009
S
Sandra M. E. Geurts
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
1.0K
Citations
17
h-index
31
i10-index
Sandra M. E. Geurts is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research. The author has an h-index of 17, co-authored 84 publications.
ORCID: 0000-0002-4265-9968Papers by this author
worksLong-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study
2022 · European Journal of Cancer · 28 citations
https://doi.org/10.1016/j.ejca.2022.06.003
Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry
2020 · Quality of Life Research · 18 citations
https://doi.org/10.1007/s11136-020-02604-4
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial
2025 · ESMO Open · 13 citations
https://doi.org/10.1016/j.esmoop.2025.104154
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
2025 · The Lancet · 13 citations
https://doi.org/10.1016/s0140-6736(25)01013-x
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
2021 · Value in Health · 11 citations
https://doi.org/10.1016/j.jval.2020.12.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat